These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 22057000)
1. The oxytocin/vasopressin receptor family has at least five members in the gnathostome lineage, inclucing two distinct V2 subtypes. Ocampo Daza D; Lewicka M; Larhammar D Gen Comp Endocrinol; 2012 Jan; 175(1):135-43. PubMed ID: 22057000 [TBL] [Abstract][Full Text] [Related]
2. The emergence of the vasopressin and oxytocin hormone receptor gene family lineage: Clues from the characterization of vasotocin receptors in the sea lamprey (Petromyzon marinus). Mayasich SA; Clarke BL Gen Comp Endocrinol; 2016 Jan; 226():88-101. PubMed ID: 26764211 [TBL] [Abstract][Full Text] [Related]
3. The fifth neurohypophysial hormone receptor is structurally related to the V2-type receptor but functionally similar to V1-type receptors. Yamaguchi Y; Kaiya H; Konno N; Iwata E; Miyazato M; Uchiyama M; Bell JD; Toop T; Donald JA; Brenner S; Venkatesh B; Hyodo S Gen Comp Endocrinol; 2012 Sep; 178(3):519-28. PubMed ID: 22809669 [TBL] [Abstract][Full Text] [Related]
4. The vertebrate ancestral repertoire of visual opsins, transducin alpha subunits and oxytocin/vasopressin receptors was established by duplication of their shared genomic region in the two rounds of early vertebrate genome duplications. Lagman D; Ocampo Daza D; Widmark J; Abalo XM; Sundström G; Larhammar D BMC Evol Biol; 2013 Nov; 13():238. PubMed ID: 24180662 [TBL] [Abstract][Full Text] [Related]
5. Identification of multiple vasotocin receptor cDNAs in teleost fish: sequences, phylogenetic analysis, sites of expression, and regulation in the hypothalamus and gill in response to hyperosmotic challenge. Lema SC Mol Cell Endocrinol; 2010 Jun; 321(2):215-30. PubMed ID: 20167249 [TBL] [Abstract][Full Text] [Related]
6. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems. Slusarz MJ; Giełdoń A; Slusarz R; Ciarkowski J J Pept Sci; 2006 Mar; 12(3):180-9. PubMed ID: 16114100 [TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8. Pena A; Murat B; Trueba M; Ventura MA; Wo NC; Szeto HH; Cheng LL; Stoev S; Guillon G; Manning M J Med Chem; 2007 Feb; 50(4):835-47. PubMed ID: 17300166 [TBL] [Abstract][Full Text] [Related]
8. Vasotocin and the origins of the vasopressin/oxytocin receptor gene family. Mayasich SA; Clarke BL Vitam Horm; 2020; 113():1-27. PubMed ID: 32138945 [TBL] [Abstract][Full Text] [Related]
9. Isosteric substitution of Asn5 in antagonists of oxytocin and vasopressin leads to highly selective and potent oxytocin and V1a receptor antagonists: new approaches for the design of potential tocolytics for preterm labor. Chan WY; Wo NC; Cheng LL; Manning M J Pharmacol Exp Ther; 1996 May; 277(2):999-1003. PubMed ID: 8627583 [TBL] [Abstract][Full Text] [Related]
11. [Hormones of the posterior region of the hypophyseal gland]. Mircić GM; Beleslin DB; Janković SM Srp Arh Celok Lek; 1998; 126(3-4):111-8. PubMed ID: 9863366 [TBL] [Abstract][Full Text] [Related]
12. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents. Manning M; Stoev S; Chini B; Durroux T; Mouillac B; Guillon G Prog Brain Res; 2008; 170():473-512. PubMed ID: 18655903 [TBL] [Abstract][Full Text] [Related]
13. Molecular neurobiology and pharmacology of the vasopressin/oxytocin receptor family. Peter J; Burbach H; Adan RA; Lolait SJ; van Leeuwen FW; Mezey E; Palkovits M; Barberis C Cell Mol Neurobiol; 1995 Oct; 15(5):573-95. PubMed ID: 8719042 [TBL] [Abstract][Full Text] [Related]
14. Mutual regulation of vasopressin- and oxytocin-induced glucagon secretion in V1b vasopressin receptor knockout mice. Fujiwara Y; Hiroyama M; Sanbe A; Yamauchi J; Tsujimoto G; Tanoue A J Endocrinol; 2007 Feb; 192(2):361-9. PubMed ID: 17283236 [TBL] [Abstract][Full Text] [Related]
15. Agonist selectivity in the oxytocin/vasopressin receptor family: new insights and challenges. Chini B; Manning M Biochem Soc Trans; 2007 Aug; 35(Pt 4):737-41. PubMed ID: 17635137 [TBL] [Abstract][Full Text] [Related]
16. Vasopressin V1a and V1b receptors: from molecules to physiological systems. Koshimizu TA; Nakamura K; Egashira N; Hiroyama M; Nonoguchi H; Tanoue A Physiol Rev; 2012 Oct; 92(4):1813-64. PubMed ID: 23073632 [TBL] [Abstract][Full Text] [Related]
17. Molecular cloning and characterization of V2-type receptor in two ray-finned fish, gray bichir, Polypterus senegalus and medaka, Oryzias latipes. Konno N; Kurosawa M; Kaiya H; Miyazato M; Matsuda K; Uchiyama M Peptides; 2010 Jul; 31(7):1273-9. PubMed ID: 20420873 [TBL] [Abstract][Full Text] [Related]
18. Oxytocin and vasopressin stimulate anion secretion by human and porcine vas deferens epithelia. Hagedorn TM; Carlin RW; Schultz BD Biol Reprod; 2007 Sep; 77(3):416-24. PubMed ID: 17442854 [TBL] [Abstract][Full Text] [Related]
19. Signal transduction pathways of the human V1-vascular, V2-renal, V3-pituitary vasopressin and oxytocin receptors. Thibonnier M; Berti-Mattera LN; Dulin N; Conarty DM; Mattera R Prog Brain Res; 1998; 119():147-61. PubMed ID: 10074787 [TBL] [Abstract][Full Text] [Related]